TherapeuticsMD Inc (TXMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While insider buying is a positive indicator, the company's financial performance shows declining net income and EPS, which raises concerns about profitability. Additionally, technical indicators and options data do not suggest a strong entry point. Given the lack of significant positive catalysts and weak financial trends, holding off on this investment is recommended.

Technical Analysis

The MACD histogram is negative (-0.029) and contracting, RSI is at 39.776 (neutral zone), and moving averages are converging. The stock is trading below the pivot level of 2.326, with key support at 2.192 and resistance at 2.459. No strong bullish signals are present.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Insider buying has increased by 399.50% over the last month, which indicates confidence from company insiders.

Neutral/Negative Catalysts

Declining financial performance with net income down -124.96% YoY and EPS down -120.00% YoY in the latest quarter. No recent news or significant trading trends. Pre-market price is down -0.75%.

Financial Performance

In Q3 2025, revenue increased by 43.33% YoY to $784,000, but net income dropped by -124.96% YoY to $152,000, and EPS fell by -120.00% YoY to 0.01. Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast TXMD stock price to rise

Buy

Hold

Sell

Current: 2.260

Low

Averages

High